Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff

Last updated: March 15, 2021
Sponsor: South Valley University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Covid-19

Treatment

N/A

Clinical Study ID

NCT04723459
SVU MED CIT0 23 4 21 1 121
  • Ages > 18
  • All Genders

Study Summary

Antiviral efficacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution will theoretically increase the protective action of the ordinary masks

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • health care personells and family contact of confirmed COVID-19 cases.

Exclusion

Exclusion Criteria:

  • refusal of participate to use the masks.
  • pregnancy or lactation known hypersensitivity to ivermectin.

Study Design

Total Participants: 150
Study Start date:
January 23, 2021
Estimated Completion Date:
March 28, 2021

Study Description

Antiviral effecacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution will theoretically increase the protective action of the ordinary masks this study is a trial for evaluation of adding a proved antiviral material to the mask and to compare between the protective value of this mask and the ordinary one.

Connect with a study center

  • Zaky Aref

    Qina, 83511
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.